Quick Summary
Obesema 0.25mg Injection
Last updated on 29 Sep 2026 | 07:07 AM (IST)
₹1637
MRP: ₹1800
(You Save ₹163)
1 PREFILLED PEN(s)
Obesema 0.25mg Injection
Salt Composition
SEMAGLUTIDEMarketer
ALKEM LABORATORIES LTD
Prepaid Only. Non-Returnable.
9% OFF
₹1637
MRP: ₹1,800.00
Inclusive of all taxes
9% Off
Salt Composition
SEMAGLUTIDEMarketer
ALKEM LABORATORIES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Semawin 0.25mg Pen injection
INTAS PHARMACEU...
₹ 272.75/injection
33% cheaper
Semaneo 0.25mg Pen Injection
INTAS PHARMACEU...
₹ 287.75/injection
29% cheaper
Semasize 0.25mg Injection PFS
ALKEM LABORATOR...
₹ 319.00/injection
22% cheaper
Hepaglide 0.25mg Injection
ALKEM LABORATOR...
₹ 409.25/injection
0% cheaper
Introduction
Obesema 0.25mg Injection contains Semaglutide, a GLP-1 receptor agonist. It is a prescription injection used for type 2 diabetes mellitus and chronic weight management in eligible adults.
The 0.25 mg strength is generally used as the starting dose of Semaglutide treatment before gradual dose escalation.
Uses
Obesema 0.25mg Injection is used:
To improve blood sugar control in adults with type 2 diabetes mellitus, along with diet and exercise.
For chronic weight management in eligible adults with obesity or overweight with a weight-related health condition.
How Obesema 0.25mg Injection Works
Semaglutide activates GLP-1 receptors involved in blood glucose and appetite regulation. It increases insulin release when blood sugar is elevated and reduces glucagon release.
It also slows stomach emptying and increases fullness, which can help reduce food intake.
Interaction of Obesema 0.25mg Injection with Other Medicines
Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and supplements you take.
Insulin and sulfonylureas: May increase the risk of low blood sugar.
Oral medicines: Semaglutide slows stomach emptying and may affect absorption.
Other Semaglutide or GLP-1 medicines: Do not combine unless specifically prescribed.
Storage Conditions
Store Obesema according to the product instructions.
Keep refrigerated at 2°C to 8°C before use unless otherwise specified.
Do not freeze.
Protect from light.
Keep out of the sight and reach of children.
How to Use
Obesema 0.25mg Injection is generally administered once weekly by subcutaneous injection into the abdomen, thigh or upper arm.
The 0.25 mg dose is generally given for the first four weeks before increasing to 0.5 mg, as tolerated and prescribed. This gradual increase helps reduce gastrointestinal side effects.
Do not increase the dose without medical advice.
Safety Advice
Pregnancy
Do not use Semaglutide for weight management during pregnancy. If planning pregnancy, speak with your doctor about stopping treatment at least 2 months beforehand.
Breast Feeding
Semaglutide should not be used while breastfeeding because its safety for the breastfed baby has not been established.
Lungs
Tell your doctor before surgery or deep sedation because delayed stomach emptying may increase aspiration risk.
Liver
Tell your doctor if you have liver disease.
Alcohol
Discuss alcohol consumption with your doctor.
Driving
Dizziness or low blood sugar may affect alertness.
Side Effects
Common side effects:
Nausea
Vomiting
Diarrhoea
Constipation
Abdominal pain
Headache
Indigestion
Dizziness
Serious side effects:
Pancreatitis
Severe allergic reactions
Gallbladder problems
Dehydration
Hypoglycaemia with insulin or sulfonylureas
Vision changes
Symptoms of thyroid tumours
Seek medical attention promptly if serious symptoms occur.
Expert Tips
Use Obesema 0.25mg once weekly as prescribed.
Do not increase the dose before the recommended treatment period.
Follow the pen instructions carefully.
Use a new needle for every injection.
Rotate injection sites.
Eat smaller meals if nausea occurs.
Drink enough fluids.
Tell your doctor about any planned surgery.
FAQs
Q1.
What is Obesema 0.25mg Injection used for?
It is used for type 2 diabetes mellitus and chronic weight management in eligible adults.
Q2.
Is Obesema 0.25mg the starting dose?
Yes. Semaglutide injection is generally started at 0.25 mg once weekly for four weeks before dose escalation.
Q3.
How long do I need to use Obesema 0.25mg?
The 0.25 mg dose is generally used during treatment initiation rather than as the long-term maintenance dose. Your doctor will decide when and whether to increase it.
Q4.
Can Obesema 0.25mg cause nausea?
Yes. Nausea is one of the most common side effects of Semaglutide, particularly during the initial dose-escalation period.
Q5.
Can I take Obesema 0.25mg with another GLP-1 medicine?
No. Do not combine it with another Semaglutide-containing medicine or GLP-1 receptor agonist unless your doctor specifically advises you to do so.
Fact Box
Molecule name: | Semaglutide |
Therapeutic class: | Antidiabetic agent / Anti-obesity medicine |
Pharmacological class: | GLP-1 receptor agonist |
Indications: | Type 2 diabetes mellitus, chronic weight management |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Vishishta
M.Sc Microbiology
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 29 Sep 2026 | 07:07 AM (IST)
Want to know more?
Read Our Editorial Policy
